Is Programmatic Problematic for Pharma?

Is Programmatic Problematic for Pharma?

In the first part in a new series of podcasts with Healio, we explore the pharma industry’s issues with programmatic advertising. Zach Gursky, SVP, Digital and Innovation at Healio walks us through the issues that have made some pharma marketers reluctant to fully embrace programmatic buying and explains whether there really is any need to be concerned.

Additionally, we discuss what changes to expect for programmatic in a post-cookie world and examine the ways pharma marketers can start using programmatic more similarly to their CPG colleagues. And, of course, ultimately, how pharma marketers can successfully utilize programmatic for their brands.

Featuring: Zach Gursky, SVP, Digital and Innovation, Healio

Sign up to listen to the podcast as well as receive an alert when the next installment in the series comes out.

As a teaser, we will be speaking with Phil Calvin, CTO, Vineti about how to evolve and mature the use technology within biotech and pharma, including the use of the cloud, AI, blockchain, and more.

Name*
First Last
Title*
Best describes your role*
Company*
Best describes your title level*
Type of Company*
Best describes your company*
Email*
Telephone*
I’d like to receive/continue to receive a FREE subscription to PM360.*
- Y(if selecting yes, please fill out address)
- No
Yes (if selecting yes, please fill out address)
Address*
Street Address Address Line 2 City State / Province / Region ZIP / Postal Code Country